Manulife (Manufacturers Life Insurance)’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Buy |
89,677
+15,867
| +21% | +$57.8K | ﹤0.01% | 2359 |
|
|
2025
Q1 | $142K | Sell |
73,810
-1,807
| -2% | -$3.47K | ﹤0.01% | 2601 |
|
|
2024
Q4 | $144K | Sell |
75,617
-2,827
| -4% | -$5.37K | ﹤0.01% | 2731 |
|
|
2024
Q3 | $104K | Buy |
+78,444
| New | +$104K | ﹤0.01% | 2862 |
|
|
2022
Q2 | – | Sell |
-78,736
| Closed | -$56.5K | – | 3001 |
|
|
2022
Q1 | $56.5K | Sell |
78,736
-20,212
| -20% | -$14.5K | ﹤0.01% | 3034 |
|
|
2021
Q4 | $224 | Sell |
98,948
-3,942
| -4% | -$9 | ﹤0.01% | 2830 |
|
|
2021
Q3 | $296K | Buy |
102,890
+7,940
| +8% | +$22.8K | ﹤0.01% | 2676 |
|
|
2021
Q2 | $360K | Buy |
94,950
+6,285
| +7% | +$23.8K | ﹤0.01% | 2675 |
|
|
2021
Q1 | $300K | Sell |
88,665
-1,786
| -2% | -$6.04K | ﹤0.01% | 2626 |
|
|
2020
Q4 | $253K | Buy |
90,451
+9,106
| +11% | +$25.5K | ﹤0.01% | 2620 |
|
|
2020
Q3 | $204K | Buy |
81,345
+3,869
| +5% | +$9.7K | ﹤0.01% | 2553 |
|
|
2020
Q2 | $984K | Buy |
77,476
+1,614
| +2% | +$20.5K | ﹤0.01% | 1625 |
|
|
2020
Q1 | $575K | Buy |
75,862
+3,933
| +5% | +$29.8K | ﹤0.01% | 1761 |
|
|
2019
Q4 | $455K | Sell |
71,929
-3,002
| -4% | -$19K | ﹤0.01% | 2105 |
|
|
2019
Q3 | $309K | Hold |
74,931
| – | – | ﹤0.01% | 2302 |
|
|
2019
Q2 | $363K | Buy |
74,931
+17,262
| +30% | +$83.6K | ﹤0.01% | 2245 |
|
|
2019
Q1 | $472K | Buy |
57,669
+1,991
| +4% | +$16.3K | ﹤0.01% | 2118 |
|
|
2018
Q4 | $308K | Buy |
55,678
+20,654
| +59% | +$114K | ﹤0.01% | 2158 |
|
|
2018
Q3 | $309K | Sell |
35,024
-4,917
| -12% | -$43.4K | ﹤0.01% | 2529 |
|
|
2018
Q2 | $399K | Buy |
39,941
+5,620
| +16% | +$56.1K | ﹤0.01% | 2568 |
|
|
2018
Q1 | $327K | Sell |
34,321
-404
| -1% | -$3.85K | ﹤0.01% | 2648 |
|
|
2017
Q4 | $516K | Buy |
34,725
+93
| +0.3% | +$1.38K | ﹤0.01% | 2300 |
|
|
2017
Q3 | $681K | Buy |
34,632
+4,904
| +16% | +$96.4K | ﹤0.01% | 2054 |
|
|
2017
Q2 | $427K | Sell |
29,728
-651
| -2% | -$9.35K | ﹤0.01% | 2414 |
|
|
2017
Q1 | $279K | Buy |
30,379
+3,344
| +12% | +$30.7K | ﹤0.01% | 2600 |
|
|
2016
Q4 | $281K | Buy |
27,035
+629
| +2% | +$6.54K | ﹤0.01% | 2527 |
|
|
2016
Q3 | $239K | Buy |
26,406
+117
| +0.4% | +$1.06K | ﹤0.01% | 2635 |
|
|
2016
Q2 | $196K | Buy |
26,289
+7,000
| +36% | +$52.2K | ﹤0.01% | 2723 |
|
|
2016
Q1 | $172K | Buy |
19,289
+1,790
| +10% | +$16K | ﹤0.01% | 2703 |
|
|
2015
Q4 | $226 | Hold |
17,499
| – | – | ﹤0.01% | 2563 |
|
|
2015
Q3 | $170 | Buy |
17,499
+108
| +0.6% | +$1 | ﹤0.01% | 2779 |
|
|
2015
Q2 | $179 | Buy |
17,391
+15,432
| +788% | +$159 | ﹤0.01% | 2946 |
|
|
2015
Q1 | $22 | Buy |
1,959
+365
| +23% | +$4 | ﹤0.01% | 3452 |
|
|
2014
Q4 | $18 | Sell |
1,594
-4,022
| -72% | -$45 | ﹤0.01% | 3379 |
|
|
2014
Q3 | $125 | Buy |
5,616
+441
| +9% | +$10 | ﹤0.01% | 2969 |
|
|
2014
Q2 | $144K | Buy |
+5,175
| New | +$144K | ﹤0.01% | 2962 |
|